SAREPTA THERAPEUTICS, INC. Financing Receivable, Not Past Due
SAREPTA THERAPEUTICS, INC. (SRPT) had Financing Receivable, Not Past Due of $20.00 million as of 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Notes › Receivables
us-gaap:FinancingReceivableRecordedInvestmentCurrent · last filed 2019-08-07
- 2019-06-30: Financing Receivable, Not Past Due $20.00M.
- 2019-03-31: Financing Receivable, Not Past Due $42.30M.
| Period end | Financing Receivable, Not Past Due |
|---|---|
| 2019-06-30 | $20.00M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $42.30M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |